Journal article Open Access

Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure

Laura Lorenzo-Soler; Ólöf B. Ólafsdóttir; Gerhard Garhöfer; Phatsawee Jansook; Íris Mýrdal Krístinsdóttir; Aimin Tan; Thorsteinn Loftsson; Einar Stefánsson


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2020-11-16</subfield>
  </datafield>
  <controlfield tag="005">20210226002728.0</controlfield>
  <controlfield tag="001">4561890</controlfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="o">oai:zenodo.org:4561890</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Orally administered angiotensin II receptor blockers (ARBs) decrease intraocular pressure (IOP). Topical administration may reduce systemic side effects and result in a useful glaucoma drug. The aim of this study is to test the ocular delivery and pharmacologic effect of nanoparticle eye drops containing ARBs (e.g. irbesartan and candesartan).&lt;br&gt;
1.5% irbesartan and 0.15% candesartan eye drops were applied to rabbits. The pharmacokinetics in cornea and aqueous humour after single eye drop application were studied in 49 rabbits. The effect of the eye drops on IOP was studied in 10 rabbits using an iCare ( TonoVet Plus, iCare, Finland) tonometer and compared with 0.5% timolol eye drops.&lt;br&gt;
Candesartan lowered IOP from 24.6 &amp;plusmn; 5.1 mmHg at baseline to 19.0 &amp;plusmn; 2.9 mmHg (mean &amp;plusmn; SD, p = 0.030, n = 10) 4 hr after application.&lt;br&gt;
Irbesartan lowered IOP from 24.2 &amp;plusmn; 1.7 mmHg to 20.2 &amp;plusmn; 0.9 mmHg (p = 0.14, n = 10). Timolol decreased the IOP from 24.9 &amp;plusmn; 4.2 mmHg to 20.4 &amp;plusmn; 4.8 mmHg (mean &amp;plusmn; SD, p = 0.036, n = 10). The pharmacokinetics data show that both formulations deliver effective amounts of drug into the intraocular tissues, with irbesartan and candesartan reaching concentrations of 121&amp;plusmn; 69 and 30.43 &amp;plusmn; 13.93 ng/g (mean &amp;plusmn; SD), respectively, in the aqueous humour 3 hr after a single-dose administration.&lt;br&gt;
Topical application of irbesartan and candesartan eye drops delivers effective drug concentrations to the anterior segment of the eye in rabbits, achieving drug concentrations 100 times above the IC50 for angiotensin II receptor and showing an IOP-lowering effect. Angiotensin receptor blocker (ARB) eye drops have potential as a new class of glaucoma drugs.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">University of Iceland</subfield>
    <subfield code="a">Ólöf B. Ólafsdóttir</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Medical University of Vienna</subfield>
    <subfield code="a">Gerhard Garhöfer</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Chulalongkorn University</subfield>
    <subfield code="a">Phatsawee Jansook</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Oculis ehf.</subfield>
    <subfield code="a">Íris Mýrdal Krístinsdóttir</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Nucro-Technics</subfield>
    <subfield code="a">Aimin Tan</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">University of Iceland</subfield>
    <subfield code="a">Thorsteinn Loftsson</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">University of Iceland</subfield>
    <subfield code="a">Einar Stefánsson</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">263323</subfield>
    <subfield code="z">md5:681c0b528c94f36d0795b4bedf8e67ae</subfield>
    <subfield code="u">https://zenodo.org/record/4561890/files/aos.14639.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">University of Iceland</subfield>
    <subfield code="0">(orcid)0000-0002-2514-1323</subfield>
    <subfield code="a">Laura Lorenzo-Soler</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">angiotensin receptor blockers</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">intraocular pressure</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">cyclodextrins</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">pharmacokinetics</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1111/aos.14639</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="q">alternateidentifier</subfield>
    <subfield code="a">10.1111/aos.14639</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="q">alternateidentifier</subfield>
    <subfield code="a">33191620</subfield>
    <subfield code="2">pmid</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure</subfield>
  </datafield>
  <datafield tag="536" ind1=" " ind2=" ">
    <subfield code="c">765441</subfield>
    <subfield code="a">Educating the next generation of scientists in translational medicine: Focus on eye diseases</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
</record>
9
56
views
downloads
Views 9
Downloads 56
Data volume 14.7 MB
Unique views 6
Unique downloads 54

Share

Cite as